Global Precision Oncology Market Research Report 2025(Status and Outlook)
Report Overview
Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.
This report provides a deep insight into the global Precision Oncology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Precision Oncology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Precision Oncology market in any manner.
Global Precision Oncology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina
Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology
Inc.
Thermo Fisher Scientific Inc.
Variantyx
Inc.
Market Segmentation (by Type)
Diagnostics
Therapeutics
Market Segmentation (by Application)
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Precision Oncology Market
Overview of the regional outlook of the Precision Oncology Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Precision Oncology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.
This report provides a deep insight into the global Precision Oncology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Precision Oncology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Precision Oncology market in any manner.
Global Precision Oncology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina
Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology
Inc.
Thermo Fisher Scientific Inc.
Variantyx
Inc.
Market Segmentation (by Type)
Diagnostics
Therapeutics
Market Segmentation (by Application)
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Precision Oncology Market
Overview of the regional outlook of the Precision Oncology Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Precision Oncology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Precision Oncology
1.2 Key Market Segments
1.2.1 Precision Oncology Segment by Type
1.2.2 Precision Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL PRECISION ONCOLOGY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Precision Oncology Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Precision Oncology Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL PRECISION ONCOLOGY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Precision Oncology Product Life Cycle
3.3 Global Precision Oncology Sales by Manufacturers (2020-2025)
3.4 Global Precision Oncology Revenue Market Share by Manufacturers (2020-2025)
3.5 Precision Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Precision Oncology Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Precision Oncology Manufacturing Sites, Area Served, Product Type
3.8 Precision Oncology Market Competitive Situation and Trends
3.8.1 Precision Oncology Market Concentration Rate
3.8.2 Global 5 and 10 Largest Precision Oncology Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PRECISION ONCOLOGY INDUSTRY CHAIN ANALYSIS
4.1 Precision Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRECISION ONCOLOGY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Precision Oncology Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Precision Oncology Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL PRECISION ONCOLOGY MARKET BY REGION
6.1 Global Precision Oncology Market Size by Region
6.1.1 Global Precision Oncology Market Size by Region
6.1.2 Global Precision Oncology Market Size Market Share by Region
6.2 Global Precision Oncology Sales by Region
6.2.1 Global Precision Oncology Sales by Region
6.2.2 Global Precision Oncology Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Precision Oncology Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Precision Oncology Market Size by Type
7.3 North America Precision Oncology Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Precision Oncology Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Precision Oncology Market Size by Type
8.3 Europe Precision Oncology Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Precision Oncology Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Precision Oncology Market Size by Type
9.3 Asia-Pacific Precision Oncology Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Precision Oncology Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Precision Oncology Market Size by Type
10.3 South America Precision Oncology Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Precision Oncology Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Precision Oncology Market Size by Type
11.3 Middle East and Africa Precision Oncology Market Size by Application
12 PRECISION ONCOLOGY MARKET PRODUCTION BY REGION
12.1 Global Production of Precision Oncology by Region(2020-2025)
12.2 Global Precision Oncology Revenue Market Share by Region (2020-2025)
12.3 Global Precision Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Precision Oncology Production
12.4.1 North America Precision Oncology Production Growth Rate (2020-2025)
12.4.2 North America Precision Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Precision Oncology Production
12.5.1 Europe Precision Oncology Production Growth Rate (2020-2025)
12.5.2 Europe Precision Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Precision Oncology Production (2020-2025)
12.6.1 Japan Precision Oncology Production Growth Rate (2020-2025)
12.6.2 Japan Precision Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Precision Oncology Production (2020-2025)
12.7.1 China Precision Oncology Production Growth Rate (2020-2025)
12.7.2 China Precision Oncology Production, Revenue, Price and Gross Margin (2020-2025)
13 PRECISION ONCOLOGY MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Precision Oncology Sales Market Share by Type (2020-2033)
13.3 Global Precision Oncology Market Size Market Share by Type (2020-2033)
13.4 Global Precision Oncology Price by Type (2020-2033)
14 PRECISION ONCOLOGY MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Precision Oncology Market Sales by Application (2020-2033)
14.3 Global Precision Oncology Market Size (M USD) by Application (2020-2033)
14.4 Global Precision Oncology Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Acrivon Therapeutics
15.1.1 Acrivon Therapeutics Basic Information
15.1.2 Acrivon Therapeutics Precision Oncology Product Overview
15.1.3 Acrivon Therapeutics Precision Oncology Product Market Performance
15.1.4 Acrivon Therapeutics Business Overview
15.1.5 Acrivon Therapeutics SWOT Analysis
15.1.6 Acrivon Therapeutics Recent Developments
15.2 Bio-Serv
15.2.1 Bio-Serv Basic Information
15.2.2 Bio-Serv Precision Oncology Product Overview
15.2.3 Bio-Serv Precision Oncology Product Market Performance
15.2.4 Bio-Serv Business Overview
15.2.5 Bio-Serv SWOT Analysis
15.2.6 Bio-Serv Recent Developments
15.3 Exact Sciences Corporation
15.3.1 Exact Sciences Corporation Basic Information
15.3.2 Exact Sciences Corporation Precision Oncology Product Overview
15.3.3 Exact Sciences Corporation Precision Oncology Product Market Performance
15.3.4 Exact Sciences Corporation Business Overview
15.3.5 Exact Sciences Corporation SWOT Analysis
15.3.6 Exact Sciences Corporation Recent Developments
15.4 Illumina
15.4.1 Illumina Basic Information
15.4.2 Illumina Precision Oncology Product Overview
15.4.3 Illumina Precision Oncology Product Market Performance
15.4.4 Illumina Business Overview
15.4.5 Illumina Recent Developments
15.5 Inc.
15.5.1 Inc. Basic Information
15.5.2 Inc. Precision Oncology Product Overview
15.5.3 Inc. Precision Oncology Product Market Performance
15.5.4 Inc. Business Overview
15.5.5 Inc. Recent Developments
15.6 Invitae Corporation
15.6.1 Invitae Corporation Basic Information
15.6.2 Invitae Corporation Precision Oncology Product Overview
15.6.3 Invitae Corporation Precision Oncology Product Market Performance
15.6.4 Invitae Corporation Business Overview
15.6.5 Invitae Corporation Recent Developments
15.7 Laboratory Corporation of America
15.7.1 Laboratory Corporation of America Basic Information
15.7.2 Laboratory Corporation of America Precision Oncology Product Overview
15.7.3 Laboratory Corporation of America Precision Oncology Product Market Performance
15.7.4 Laboratory Corporation of America Business Overview
15.7.5 Laboratory Corporation of America Recent Developments
15.8 QIAGEN
15.8.1 QIAGEN Basic Information
15.8.2 QIAGEN Precision Oncology Product Overview
15.8.3 QIAGEN Precision Oncology Product Market Performance
15.8.4 QIAGEN Business Overview
15.8.5 QIAGEN Recent Developments
15.9 Rain Oncology
15.9.1 Rain Oncology Basic Information
15.9.2 Rain Oncology Precision Oncology Product Overview
15.9.3 Rain Oncology Precision Oncology Product Market Performance
15.9.4 Rain Oncology Business Overview
15.9.5 Rain Oncology Recent Developments
15.10 Relay Therapeutics
15.10.1 Relay Therapeutics Basic Information
15.10.2 Relay Therapeutics Precision Oncology Product Overview
15.10.3 Relay Therapeutics Precision Oncology Product Market Performance
15.10.4 Relay Therapeutics Business Overview
15.10.5 Relay Therapeutics Recent Developments
15.11 Strata Oncology
15.11.1 Strata Oncology Basic Information
15.11.2 Strata Oncology Precision Oncology Product Overview
15.11.3 Strata Oncology Precision Oncology Product Market Performance
15.11.4 Strata Oncology Business Overview
15.11.5 Strata Oncology Recent Developments
15.12 Inc.
15.12.1 Inc. Basic Information
15.12.2 Inc. Precision Oncology Product Overview
15.12.3 Inc. Precision Oncology Product Market Performance
15.12.4 Inc. Business Overview
15.12.5 Inc. Recent Developments
15.13 Thermo Fisher Scientific Inc.
15.13.1 Thermo Fisher Scientific Inc. Basic Information
15.13.2 Thermo Fisher Scientific Inc. Precision Oncology Product Overview
15.13.3 Thermo Fisher Scientific Inc. Precision Oncology Product Market Performance
15.13.4 Thermo Fisher Scientific Inc. Business Overview
15.13.5 Thermo Fisher Scientific Inc. Recent Developments
15.14 Variantyx
15.14.1 Variantyx Basic Information
15.14.2 Variantyx Precision Oncology Product Overview
15.14.3 Variantyx Precision Oncology Product Market Performance
15.14.4 Variantyx Business Overview
15.14.5 Variantyx Recent Developments
15.15 Inc.
15.15.1 Inc. Basic Information
15.15.2 Inc. Precision Oncology Product Overview
15.15.3 Inc. Precision Oncology Product Market Performance
15.15.4 Inc. Business Overview
15.15.5 Inc. Recent Developments
16 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Precision Oncology
1.2 Key Market Segments
1.2.1 Precision Oncology Segment by Type
1.2.2 Precision Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL PRECISION ONCOLOGY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Precision Oncology Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Precision Oncology Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL PRECISION ONCOLOGY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Precision Oncology Product Life Cycle
3.3 Global Precision Oncology Sales by Manufacturers (2020-2025)
3.4 Global Precision Oncology Revenue Market Share by Manufacturers (2020-2025)
3.5 Precision Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Precision Oncology Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Precision Oncology Manufacturing Sites, Area Served, Product Type
3.8 Precision Oncology Market Competitive Situation and Trends
3.8.1 Precision Oncology Market Concentration Rate
3.8.2 Global 5 and 10 Largest Precision Oncology Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PRECISION ONCOLOGY INDUSTRY CHAIN ANALYSIS
4.1 Precision Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRECISION ONCOLOGY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Precision Oncology Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Precision Oncology Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL PRECISION ONCOLOGY MARKET BY REGION
6.1 Global Precision Oncology Market Size by Region
6.1.1 Global Precision Oncology Market Size by Region
6.1.2 Global Precision Oncology Market Size Market Share by Region
6.2 Global Precision Oncology Sales by Region
6.2.1 Global Precision Oncology Sales by Region
6.2.2 Global Precision Oncology Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Precision Oncology Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Precision Oncology Market Size by Type
7.3 North America Precision Oncology Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Precision Oncology Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Precision Oncology Market Size by Type
8.3 Europe Precision Oncology Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Precision Oncology Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Precision Oncology Market Size by Type
9.3 Asia-Pacific Precision Oncology Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Precision Oncology Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Precision Oncology Market Size by Type
10.3 South America Precision Oncology Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Precision Oncology Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Precision Oncology Market Size by Type
11.3 Middle East and Africa Precision Oncology Market Size by Application
12 PRECISION ONCOLOGY MARKET PRODUCTION BY REGION
12.1 Global Production of Precision Oncology by Region(2020-2025)
12.2 Global Precision Oncology Revenue Market Share by Region (2020-2025)
12.3 Global Precision Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Precision Oncology Production
12.4.1 North America Precision Oncology Production Growth Rate (2020-2025)
12.4.2 North America Precision Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Precision Oncology Production
12.5.1 Europe Precision Oncology Production Growth Rate (2020-2025)
12.5.2 Europe Precision Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Precision Oncology Production (2020-2025)
12.6.1 Japan Precision Oncology Production Growth Rate (2020-2025)
12.6.2 Japan Precision Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Precision Oncology Production (2020-2025)
12.7.1 China Precision Oncology Production Growth Rate (2020-2025)
12.7.2 China Precision Oncology Production, Revenue, Price and Gross Margin (2020-2025)
13 PRECISION ONCOLOGY MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Precision Oncology Sales Market Share by Type (2020-2033)
13.3 Global Precision Oncology Market Size Market Share by Type (2020-2033)
13.4 Global Precision Oncology Price by Type (2020-2033)
14 PRECISION ONCOLOGY MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Precision Oncology Market Sales by Application (2020-2033)
14.3 Global Precision Oncology Market Size (M USD) by Application (2020-2033)
14.4 Global Precision Oncology Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Acrivon Therapeutics
15.1.1 Acrivon Therapeutics Basic Information
15.1.2 Acrivon Therapeutics Precision Oncology Product Overview
15.1.3 Acrivon Therapeutics Precision Oncology Product Market Performance
15.1.4 Acrivon Therapeutics Business Overview
15.1.5 Acrivon Therapeutics SWOT Analysis
15.1.6 Acrivon Therapeutics Recent Developments
15.2 Bio-Serv
15.2.1 Bio-Serv Basic Information
15.2.2 Bio-Serv Precision Oncology Product Overview
15.2.3 Bio-Serv Precision Oncology Product Market Performance
15.2.4 Bio-Serv Business Overview
15.2.5 Bio-Serv SWOT Analysis
15.2.6 Bio-Serv Recent Developments
15.3 Exact Sciences Corporation
15.3.1 Exact Sciences Corporation Basic Information
15.3.2 Exact Sciences Corporation Precision Oncology Product Overview
15.3.3 Exact Sciences Corporation Precision Oncology Product Market Performance
15.3.4 Exact Sciences Corporation Business Overview
15.3.5 Exact Sciences Corporation SWOT Analysis
15.3.6 Exact Sciences Corporation Recent Developments
15.4 Illumina
15.4.1 Illumina Basic Information
15.4.2 Illumina Precision Oncology Product Overview
15.4.3 Illumina Precision Oncology Product Market Performance
15.4.4 Illumina Business Overview
15.4.5 Illumina Recent Developments
15.5 Inc.
15.5.1 Inc. Basic Information
15.5.2 Inc. Precision Oncology Product Overview
15.5.3 Inc. Precision Oncology Product Market Performance
15.5.4 Inc. Business Overview
15.5.5 Inc. Recent Developments
15.6 Invitae Corporation
15.6.1 Invitae Corporation Basic Information
15.6.2 Invitae Corporation Precision Oncology Product Overview
15.6.3 Invitae Corporation Precision Oncology Product Market Performance
15.6.4 Invitae Corporation Business Overview
15.6.5 Invitae Corporation Recent Developments
15.7 Laboratory Corporation of America
15.7.1 Laboratory Corporation of America Basic Information
15.7.2 Laboratory Corporation of America Precision Oncology Product Overview
15.7.3 Laboratory Corporation of America Precision Oncology Product Market Performance
15.7.4 Laboratory Corporation of America Business Overview
15.7.5 Laboratory Corporation of America Recent Developments
15.8 QIAGEN
15.8.1 QIAGEN Basic Information
15.8.2 QIAGEN Precision Oncology Product Overview
15.8.3 QIAGEN Precision Oncology Product Market Performance
15.8.4 QIAGEN Business Overview
15.8.5 QIAGEN Recent Developments
15.9 Rain Oncology
15.9.1 Rain Oncology Basic Information
15.9.2 Rain Oncology Precision Oncology Product Overview
15.9.3 Rain Oncology Precision Oncology Product Market Performance
15.9.4 Rain Oncology Business Overview
15.9.5 Rain Oncology Recent Developments
15.10 Relay Therapeutics
15.10.1 Relay Therapeutics Basic Information
15.10.2 Relay Therapeutics Precision Oncology Product Overview
15.10.3 Relay Therapeutics Precision Oncology Product Market Performance
15.10.4 Relay Therapeutics Business Overview
15.10.5 Relay Therapeutics Recent Developments
15.11 Strata Oncology
15.11.1 Strata Oncology Basic Information
15.11.2 Strata Oncology Precision Oncology Product Overview
15.11.3 Strata Oncology Precision Oncology Product Market Performance
15.11.4 Strata Oncology Business Overview
15.11.5 Strata Oncology Recent Developments
15.12 Inc.
15.12.1 Inc. Basic Information
15.12.2 Inc. Precision Oncology Product Overview
15.12.3 Inc. Precision Oncology Product Market Performance
15.12.4 Inc. Business Overview
15.12.5 Inc. Recent Developments
15.13 Thermo Fisher Scientific Inc.
15.13.1 Thermo Fisher Scientific Inc. Basic Information
15.13.2 Thermo Fisher Scientific Inc. Precision Oncology Product Overview
15.13.3 Thermo Fisher Scientific Inc. Precision Oncology Product Market Performance
15.13.4 Thermo Fisher Scientific Inc. Business Overview
15.13.5 Thermo Fisher Scientific Inc. Recent Developments
15.14 Variantyx
15.14.1 Variantyx Basic Information
15.14.2 Variantyx Precision Oncology Product Overview
15.14.3 Variantyx Precision Oncology Product Market Performance
15.14.4 Variantyx Business Overview
15.14.5 Variantyx Recent Developments
15.15 Inc.
15.15.1 Inc. Basic Information
15.15.2 Inc. Precision Oncology Product Overview
15.15.3 Inc. Precision Oncology Product Market Performance
15.15.4 Inc. Business Overview
15.15.5 Inc. Recent Developments
16 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Precision Oncology Market Size by Type (M USD)
Table 4. Global Precision Oncology Market Size by Application (M USD)
Table 5. Precision Oncology Market Size Comparison by Region (M USD)
Table 6. Global Precision Oncology Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Precision Oncology Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Precision Oncology Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Precision Oncology Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2024)
Table 11. Global Market Precision Oncology Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Precision Oncology Manufacturing Sites and Area Served
Table 13. Manufacturers Precision Oncology Product Type
Table 14. Global Precision Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Precision Oncology Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Precision Oncology Market Size Comparison by Region (M USD)
Table 26. Global Precision Oncology Market Size by Region (2020-2033) & (M USD)
Table 27. Global Precision Oncology Market Size Market Share by Region (2020-2033)
Table 28. Global Precision Oncology Sales by Region (2020-2033) & (K Units)
Table 29. Global Precision Oncology Sales Market Share by Region (2020-2033)
Table 30. North America Precision Oncology Market Size by Country (2020-2033) & (M USD)
Table 31. North America Precision Oncology Sales by Country (2020-2033) & (K Units)
Table 32. North America Precision Oncology Sales by Type (K Units)
Table 33. North America Precision Oncology Market Size by Type (M USD)
Table 34. North America Precision Oncology Sales (K Units) by Type (2020-2033)
Table 35. North America Precision Oncology Market Size (M USD) by Type (2020-2033)
Table 36. North America Precision Oncology Sales by Application (K Units)
Table 37. North America Precision Oncology Market Size by Application (M USD)
Table 38. North America Precision Oncology Sales (K Units) by Application (2020-2033)
Table 39. North America Precision Oncology Market Size (M USD) by Application (2020-2033)
Table 40. Europe Precision Oncology Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Precision Oncology Sales by Country (2020-2033) & (K Units)
Table 42. Europe Precision Oncology Sales by Type (K Units)
Table 43. Europe Precision Oncology Market Size by Type (M USD)
Table 44. Europe Precision Oncology Sales (K Units) by Type (2020-2033)
Table 45. Europe Precision Oncology Market Size (M USD) by Type (2020-2033)
Table 46. Europe Precision Oncology Sales by Application (K Units)
Table 47. Europe Precision Oncology Market Size by Application (M USD)
Table 48. Europe Precision Oncology Sales (K Units) by Application (2020-2033)
Table 49. Europe Precision Oncology Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Precision Oncology Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Precision Oncology Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Precision Oncology Sales by Type (K Units)
Table 53. Asia-Pacific Precision Oncology Market Size by Type (M USD)
Table 54. Asia-Pacific Precision Oncology Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Precision Oncology Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Precision Oncology Sales by Application (K Units)
Table 57. Asia-Pacific Precision Oncology Market Size by Application (M USD)
Table 58. Asia-Pacific Precision Oncology Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Precision Oncology Market Size (M USD) by Application (2020-2025)
Table 60. South America Precision Oncology Market Size by Country (2020-2033) & (M USD)
Table 61. South America Precision Oncology Sales by Country (2020-2033) & (K Units)
Table 62. South America Precision Oncology Sales by Type (K Units)
Table 63. South America Precision Oncology Market Size by Type (M USD)
Table 64. South America Precision Oncology Sales (K Units) by Type (2020-2033)
Table 65. South America Precision Oncology Market Size (M USD) by Type (2020-2033)
Table 66. South America Precision Oncology Sales by Application (K Units)
Table 67. South America Precision Oncology Market Size by Application (M USD)
Table 68. South America Precision Oncology Sales (K Units) by Application (2020-2033)
Table 69. South America Precision Oncology Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Precision Oncology Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Precision Oncology Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Precision Oncology Sales by Type (K Units)
Table 73. Middle East and Africa Precision Oncology Market Size by Type (M USD)
Table 74. Middle East and Africa Precision Oncology Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Precision Oncology Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Precision Oncology Sales by Application (K Units)
Table 77. Middle East and Africa Precision Oncology Market Size by Application (M USD)
Table 78. Middle East and Africa Precision Oncology Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Precision Oncology Market Size (M USD) by Application (2020-2033)
Table 80. Global Precision Oncology Production (K Units) by Region(2020-2025)
Table 81. Global Precision Oncology Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Precision Oncology Revenue Market Share by Region (2020-2025)
Table 83. Global Precision Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Precision Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Precision Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Precision Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Precision Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Precision Oncology Sales by Type (K Units)
Table 89. Global Precision Oncology Market Size by Type (M USD)
Table 90. Global Precision Oncology Sales (K Units) by Type (2020-2033)
Table 91. Global Precision Oncology Sales Market Share by Type (2020-2033)
Table 92. Global Precision Oncology Market Size (M USD) by Type (2020-2033)
Table 93. Global Precision Oncology Market Size Share by Type (2020-2033)
Table 94. Global Precision Oncology Sales (K Units) by Application
Table 95. Global Precision Oncology Market Size by Application(M USD)
Table 96. Global Precision Oncology Sales by Application (2020-2033) & (K Units)
Table 97. Global Precision Oncology Sales Market Share by Application (2020-2033)
Table 98. Global Precision Oncology Market Size by Application (2020-2033) & (M USD)
Table 99. Global Precision Oncology Market Share by Application (2020-2033)
Table 100. Global Precision Oncology Sales Growth Rate by Application (2020-2033)
Table 101. Acrivon Therapeutics Basic Information
Table 102. Acrivon Therapeutics Precision Oncology Product Overview
Table 103. Acrivon Therapeutics Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Acrivon Therapeutics Business Overview
Table 105. Acrivon Therapeutics SWOT Analysis
Table 106. Acrivon Therapeutics Recent Developments
Table 107. Bio-Serv Basic Information
Table 108. Bio-Serv Precision Oncology Product Overview
Table 109. Bio-Serv Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Bio-Serv Business Overview
Table 111. Bio-Serv SWOT Analysis
Table 112. Bio-Serv Recent Developments
Table 113. Exact Sciences Corporation Basic Information
Table 114. Exact Sciences Corporation Precision Oncology Product Overview
Table 115. Exact Sciences Corporation Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Exact Sciences Corporation Business Overview
Table 117. Exact Sciences Corporation SWOT Analysis
Table 118. Exact Sciences Corporation Recent Developments
Table 119. Illumina Basic Information
Table 120. Illumina Precision Oncology Product Overview
Table 121. Illumina Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Illumina Business Overview
Table 123. Illumina Recent Developments
Table 124. Inc. Basic Information
Table 125. Inc. Precision Oncology Product Overview
Table 126. Inc. Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Inc. Business Overview
Table 128. Inc. Recent Developments
Table 129. Invitae Corporation Basic Information
Table 130. Invitae Corporation Precision Oncology Product Overview
Table 131. Invitae Corporation Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Invitae Corporation Business Overview
Table 133. Invitae Corporation Recent Developments
Table 134. Laboratory Corporation of America Basic Information
Table 135. Laboratory Corporation of America Precision Oncology Product Overview
Table 136. Laboratory Corporation of America Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Laboratory Corporation of America Business Overview
Table 138. Laboratory Corporation of America Recent Developments
Table 139. QIAGEN Basic Information
Table 140. QIAGEN Precision Oncology Product Overview
Table 141. QIAGEN Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. QIAGEN Business Overview
Table 143. QIAGEN Recent Developments
Table 144. Rain Oncology Basic Information
Table 145. Rain Oncology Precision Oncology Product Overview
Table 146. Rain Oncology Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Rain Oncology Business Overview
Table 148. Rain Oncology Recent Developments
Table 149. Relay Therapeutics Basic Information
Table 150. Relay Therapeutics Precision Oncology Product Overview
Table 151. Relay Therapeutics Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Relay Therapeutics Business Overview
Table 153. Relay Therapeutics Recent Developments
Table 154. Strata Oncology Basic Information
Table 155. Strata Oncology Precision Oncology Product Overview
Table 156. Strata Oncology Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Strata Oncology Business Overview
Table 158. Strata Oncology Recent Developments
Table 159. Inc. Basic Information
Table 160. Inc. Precision Oncology Product Overview
Table 161. Inc. Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Inc. Business Overview
Table 163. Inc. Recent Developments
Table 164. Thermo Fisher Scientific Inc. Basic Information
Table 165. Thermo Fisher Scientific Inc. Precision Oncology Product Overview
Table 166. Thermo Fisher Scientific Inc. Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Thermo Fisher Scientific Inc. Business Overview
Table 168. Thermo Fisher Scientific Inc. Recent Developments
Table 169. Variantyx Basic Information
Table 170. Variantyx Precision Oncology Product Overview
Table 171. Variantyx Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Variantyx Business Overview
Table 173. Variantyx Recent Developments
Table 174. Inc. Basic Information
Table 175. Inc. Precision Oncology Product Overview
Table 176. Inc. Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Inc. Business Overview
Table 178. Inc. Recent Developments
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Precision Oncology Market Size by Type (M USD)
Table 4. Global Precision Oncology Market Size by Application (M USD)
Table 5. Precision Oncology Market Size Comparison by Region (M USD)
Table 6. Global Precision Oncology Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Precision Oncology Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Precision Oncology Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Precision Oncology Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2024)
Table 11. Global Market Precision Oncology Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Precision Oncology Manufacturing Sites and Area Served
Table 13. Manufacturers Precision Oncology Product Type
Table 14. Global Precision Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Precision Oncology Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Precision Oncology Market Size Comparison by Region (M USD)
Table 26. Global Precision Oncology Market Size by Region (2020-2033) & (M USD)
Table 27. Global Precision Oncology Market Size Market Share by Region (2020-2033)
Table 28. Global Precision Oncology Sales by Region (2020-2033) & (K Units)
Table 29. Global Precision Oncology Sales Market Share by Region (2020-2033)
Table 30. North America Precision Oncology Market Size by Country (2020-2033) & (M USD)
Table 31. North America Precision Oncology Sales by Country (2020-2033) & (K Units)
Table 32. North America Precision Oncology Sales by Type (K Units)
Table 33. North America Precision Oncology Market Size by Type (M USD)
Table 34. North America Precision Oncology Sales (K Units) by Type (2020-2033)
Table 35. North America Precision Oncology Market Size (M USD) by Type (2020-2033)
Table 36. North America Precision Oncology Sales by Application (K Units)
Table 37. North America Precision Oncology Market Size by Application (M USD)
Table 38. North America Precision Oncology Sales (K Units) by Application (2020-2033)
Table 39. North America Precision Oncology Market Size (M USD) by Application (2020-2033)
Table 40. Europe Precision Oncology Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Precision Oncology Sales by Country (2020-2033) & (K Units)
Table 42. Europe Precision Oncology Sales by Type (K Units)
Table 43. Europe Precision Oncology Market Size by Type (M USD)
Table 44. Europe Precision Oncology Sales (K Units) by Type (2020-2033)
Table 45. Europe Precision Oncology Market Size (M USD) by Type (2020-2033)
Table 46. Europe Precision Oncology Sales by Application (K Units)
Table 47. Europe Precision Oncology Market Size by Application (M USD)
Table 48. Europe Precision Oncology Sales (K Units) by Application (2020-2033)
Table 49. Europe Precision Oncology Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Precision Oncology Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Precision Oncology Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Precision Oncology Sales by Type (K Units)
Table 53. Asia-Pacific Precision Oncology Market Size by Type (M USD)
Table 54. Asia-Pacific Precision Oncology Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Precision Oncology Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Precision Oncology Sales by Application (K Units)
Table 57. Asia-Pacific Precision Oncology Market Size by Application (M USD)
Table 58. Asia-Pacific Precision Oncology Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Precision Oncology Market Size (M USD) by Application (2020-2025)
Table 60. South America Precision Oncology Market Size by Country (2020-2033) & (M USD)
Table 61. South America Precision Oncology Sales by Country (2020-2033) & (K Units)
Table 62. South America Precision Oncology Sales by Type (K Units)
Table 63. South America Precision Oncology Market Size by Type (M USD)
Table 64. South America Precision Oncology Sales (K Units) by Type (2020-2033)
Table 65. South America Precision Oncology Market Size (M USD) by Type (2020-2033)
Table 66. South America Precision Oncology Sales by Application (K Units)
Table 67. South America Precision Oncology Market Size by Application (M USD)
Table 68. South America Precision Oncology Sales (K Units) by Application (2020-2033)
Table 69. South America Precision Oncology Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Precision Oncology Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Precision Oncology Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Precision Oncology Sales by Type (K Units)
Table 73. Middle East and Africa Precision Oncology Market Size by Type (M USD)
Table 74. Middle East and Africa Precision Oncology Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Precision Oncology Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Precision Oncology Sales by Application (K Units)
Table 77. Middle East and Africa Precision Oncology Market Size by Application (M USD)
Table 78. Middle East and Africa Precision Oncology Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Precision Oncology Market Size (M USD) by Application (2020-2033)
Table 80. Global Precision Oncology Production (K Units) by Region(2020-2025)
Table 81. Global Precision Oncology Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Precision Oncology Revenue Market Share by Region (2020-2025)
Table 83. Global Precision Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Precision Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Precision Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Precision Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Precision Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Precision Oncology Sales by Type (K Units)
Table 89. Global Precision Oncology Market Size by Type (M USD)
Table 90. Global Precision Oncology Sales (K Units) by Type (2020-2033)
Table 91. Global Precision Oncology Sales Market Share by Type (2020-2033)
Table 92. Global Precision Oncology Market Size (M USD) by Type (2020-2033)
Table 93. Global Precision Oncology Market Size Share by Type (2020-2033)
Table 94. Global Precision Oncology Sales (K Units) by Application
Table 95. Global Precision Oncology Market Size by Application(M USD)
Table 96. Global Precision Oncology Sales by Application (2020-2033) & (K Units)
Table 97. Global Precision Oncology Sales Market Share by Application (2020-2033)
Table 98. Global Precision Oncology Market Size by Application (2020-2033) & (M USD)
Table 99. Global Precision Oncology Market Share by Application (2020-2033)
Table 100. Global Precision Oncology Sales Growth Rate by Application (2020-2033)
Table 101. Acrivon Therapeutics Basic Information
Table 102. Acrivon Therapeutics Precision Oncology Product Overview
Table 103. Acrivon Therapeutics Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Acrivon Therapeutics Business Overview
Table 105. Acrivon Therapeutics SWOT Analysis
Table 106. Acrivon Therapeutics Recent Developments
Table 107. Bio-Serv Basic Information
Table 108. Bio-Serv Precision Oncology Product Overview
Table 109. Bio-Serv Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Bio-Serv Business Overview
Table 111. Bio-Serv SWOT Analysis
Table 112. Bio-Serv Recent Developments
Table 113. Exact Sciences Corporation Basic Information
Table 114. Exact Sciences Corporation Precision Oncology Product Overview
Table 115. Exact Sciences Corporation Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Exact Sciences Corporation Business Overview
Table 117. Exact Sciences Corporation SWOT Analysis
Table 118. Exact Sciences Corporation Recent Developments
Table 119. Illumina Basic Information
Table 120. Illumina Precision Oncology Product Overview
Table 121. Illumina Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Illumina Business Overview
Table 123. Illumina Recent Developments
Table 124. Inc. Basic Information
Table 125. Inc. Precision Oncology Product Overview
Table 126. Inc. Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Inc. Business Overview
Table 128. Inc. Recent Developments
Table 129. Invitae Corporation Basic Information
Table 130. Invitae Corporation Precision Oncology Product Overview
Table 131. Invitae Corporation Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Invitae Corporation Business Overview
Table 133. Invitae Corporation Recent Developments
Table 134. Laboratory Corporation of America Basic Information
Table 135. Laboratory Corporation of America Precision Oncology Product Overview
Table 136. Laboratory Corporation of America Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Laboratory Corporation of America Business Overview
Table 138. Laboratory Corporation of America Recent Developments
Table 139. QIAGEN Basic Information
Table 140. QIAGEN Precision Oncology Product Overview
Table 141. QIAGEN Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. QIAGEN Business Overview
Table 143. QIAGEN Recent Developments
Table 144. Rain Oncology Basic Information
Table 145. Rain Oncology Precision Oncology Product Overview
Table 146. Rain Oncology Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Rain Oncology Business Overview
Table 148. Rain Oncology Recent Developments
Table 149. Relay Therapeutics Basic Information
Table 150. Relay Therapeutics Precision Oncology Product Overview
Table 151. Relay Therapeutics Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Relay Therapeutics Business Overview
Table 153. Relay Therapeutics Recent Developments
Table 154. Strata Oncology Basic Information
Table 155. Strata Oncology Precision Oncology Product Overview
Table 156. Strata Oncology Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Strata Oncology Business Overview
Table 158. Strata Oncology Recent Developments
Table 159. Inc. Basic Information
Table 160. Inc. Precision Oncology Product Overview
Table 161. Inc. Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Inc. Business Overview
Table 163. Inc. Recent Developments
Table 164. Thermo Fisher Scientific Inc. Basic Information
Table 165. Thermo Fisher Scientific Inc. Precision Oncology Product Overview
Table 166. Thermo Fisher Scientific Inc. Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Thermo Fisher Scientific Inc. Business Overview
Table 168. Thermo Fisher Scientific Inc. Recent Developments
Table 169. Variantyx Basic Information
Table 170. Variantyx Precision Oncology Product Overview
Table 171. Variantyx Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Variantyx Business Overview
Table 173. Variantyx Recent Developments
Table 174. Inc. Basic Information
Table 175. Inc. Precision Oncology Product Overview
Table 176. Inc. Precision Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Inc. Business Overview
Table 178. Inc. Recent Developments
LIST OF FIGURES
Figure 1. Product Picture of Precision Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Precision Oncology Market Size (M USD), 2024-2033
Figure 5. Global Precision Oncology Market Size (M USD) (2020-2033)
Figure 6. Global Precision Oncology Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Precision Oncology Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Precision Oncology Product Life Cycle
Figure 13. Precision Oncology Sales Share by Manufacturers in 2024
Figure 14. Global Precision Oncology Revenue Share by Manufacturers in 2024
Figure 15. Precision Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Precision Oncology Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Precision Oncology Revenue in 2024
Figure 18. Industry Chain Map of Precision Oncology
Figure 19. Global Precision Oncology Market PEST Analysis
Figure 20. Global Precision Oncology Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Precision Oncology Market Size by Region
Figure 27. Global Precision Oncology Market Size Market Share by Region (2020-2033)
Figure 28. Global Precision Oncology Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Precision Oncology Market Size (M USD) by Country
Figure 33. USA Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Precision Oncology Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Precision Oncology Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Precision Oncology Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Precision Oncology Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Precision Oncology Market Size (M USD)by Type
Figure 40. North America Precision Oncology Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Precision Oncology Market Size (M USD) by Country
Figure 45. Germany Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Precision Oncology Market Size (M USD) by Type
Figure 56. Europe Precision Oncology Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Precision Oncology Market Size (M USD) by Country
Figure 61. China Precision Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Precision Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Precision Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Precision Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Precision Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Precision Oncology Market Size (M USD) by Type
Figure 72. Asia-Pacific Precision Oncology Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Precision Oncology Market Size (M USD) by Country
Figure 77. Brazil Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Precision Oncology Market Size (M USD) by Type
Figure 84. South America Precision Oncology Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Precision Oncology Market Size (M USD) by Country
Figure 89. Saudi Arabia Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Precision Oncology Market Size (M USD) by Type
Figure 100. Middle East and Africa Precision Oncology Market Size (M USD) by Application
Figure 101. Global Precision Oncology Production Market Share by Region (2020-2025)
Figure 102. North America Precision Oncology Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Precision Oncology Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Precision Oncology Production (K Units) Growth Rate (2020-2025)
Figure 105. China Precision Oncology Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Precision Oncology Market Size by Type (M USD)
Figure 108. Sales Market Share of Precision Oncology by Type (2020-2033)
Figure 109. Sales Market Share of Precision Oncology by Type in 2024
Figure 110. Market Size Share of Precision Oncology by Type (2020-2033)
Figure 111. Market Size Share of Precision Oncology by Type in 2024
Figure 112. Global Precision Oncology Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Precision Oncology Market Size by Application(M USD)
Figure 115. Global Precision Oncology Market Share by Application
Figure 116. Global Precision Oncology Sales Market Share by Application (2020-2033)
Figure 117. Global Precision Oncology Sales Market Share by Application in 2024
Figure 118. Global Precision Oncology Market Share by Application (2020-2033)
Figure 119. Global Precision Oncology Market Share by Application in 2024
Figure 120. Global Precision Oncology Sales Growth Rate by Application (2020-2033)
Figure 1. Product Picture of Precision Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Precision Oncology Market Size (M USD), 2024-2033
Figure 5. Global Precision Oncology Market Size (M USD) (2020-2033)
Figure 6. Global Precision Oncology Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Precision Oncology Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Precision Oncology Product Life Cycle
Figure 13. Precision Oncology Sales Share by Manufacturers in 2024
Figure 14. Global Precision Oncology Revenue Share by Manufacturers in 2024
Figure 15. Precision Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Precision Oncology Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Precision Oncology Revenue in 2024
Figure 18. Industry Chain Map of Precision Oncology
Figure 19. Global Precision Oncology Market PEST Analysis
Figure 20. Global Precision Oncology Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Precision Oncology Market Size by Region
Figure 27. Global Precision Oncology Market Size Market Share by Region (2020-2033)
Figure 28. Global Precision Oncology Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Precision Oncology Market Size (M USD) by Country
Figure 33. USA Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Precision Oncology Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Precision Oncology Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Precision Oncology Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Precision Oncology Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Precision Oncology Market Size (M USD)by Type
Figure 40. North America Precision Oncology Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Precision Oncology Market Size (M USD) by Country
Figure 45. Germany Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Precision Oncology Market Size (M USD) by Type
Figure 56. Europe Precision Oncology Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Precision Oncology Market Size (M USD) by Country
Figure 61. China Precision Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Precision Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Precision Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Precision Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Precision Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Precision Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Precision Oncology Market Size (M USD) by Type
Figure 72. Asia-Pacific Precision Oncology Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Precision Oncology Market Size (M USD) by Country
Figure 77. Brazil Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Precision Oncology Market Size (M USD) by Type
Figure 84. South America Precision Oncology Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Precision Oncology Market Size (M USD) by Country
Figure 89. Saudi Arabia Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Precision Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Precision Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Precision Oncology Market Size (M USD) by Type
Figure 100. Middle East and Africa Precision Oncology Market Size (M USD) by Application
Figure 101. Global Precision Oncology Production Market Share by Region (2020-2025)
Figure 102. North America Precision Oncology Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Precision Oncology Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Precision Oncology Production (K Units) Growth Rate (2020-2025)
Figure 105. China Precision Oncology Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Precision Oncology Market Size by Type (M USD)
Figure 108. Sales Market Share of Precision Oncology by Type (2020-2033)
Figure 109. Sales Market Share of Precision Oncology by Type in 2024
Figure 110. Market Size Share of Precision Oncology by Type (2020-2033)
Figure 111. Market Size Share of Precision Oncology by Type in 2024
Figure 112. Global Precision Oncology Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Precision Oncology Market Size by Application(M USD)
Figure 115. Global Precision Oncology Market Share by Application
Figure 116. Global Precision Oncology Sales Market Share by Application (2020-2033)
Figure 117. Global Precision Oncology Sales Market Share by Application in 2024
Figure 118. Global Precision Oncology Market Share by Application (2020-2033)
Figure 119. Global Precision Oncology Market Share by Application in 2024
Figure 120. Global Precision Oncology Sales Growth Rate by Application (2020-2033)
